- MeiraGTx strikes royalty deal; Fore's 2023 Series D continuesPlus, news about Kalohexis, Teva and Agios: 👑 MeiraGTx makes royalty deal with Oberland Capital: The gene therapy maker will get an initial $135 million via a $10 million equity investment ...Endpoints · 18d ago↗ source
- STAT+: ‘Secret shopper’ study probes GLP-1 telehealth sitesIn this edition of STAT Health Tech: A 'secret shopper' study of telehealth sites prescribing GLP-1s, news about Epic, Anthropic, and brain implants.STAT · 18d ago↗ source
- Conquering Medicare's ACCESS programThere was so much excitement when CMS announced the ACCESS program. Finally, a way for digital health companies to make their mark on Medicare! A program that pays only if patients get better! Bu…Endpoints